In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. - Wikidata - wikimedia - TriplyDB

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

http://www.wikidata.org/entity/Q35074604

about

Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities Mechanisms of interleukin-22's beneficial effects in acute pancreatitis The Role of Innate Immunity in Alcoholic Liver Disease Hepatocytes: a key cell type for innate immunity STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease Interleukin-22 in kidney injury and regeneration.High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22 Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice [Liver regeneration : two pieces of the puzzle connected].Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro New drug targets for alcoholic liver disease.Combination therapy: New hope for alcoholic hepatitis?A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection.Acute and chronic effects of IL-22 on acetaminophen-induced liver injury STAT3 activation in monocytes accelerates liver cancer progression.Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.IL-22 is related to development of human colon cancer by activation of STAT3.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis.Immune modulatory effects of IL-22 on allergen-induced pulmonary inflammation.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.Interleukin-22: immunobiology and pathology.Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway.Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences.Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease Cytokines and STATs in Liver Fibrosis.Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice.Interleukin-22: implications for liver ischemia-reperfusion injury Th17 cells: critical mediators of host responses to burn injury and sepsis New Approaches for Studying Alcoholic Liver Disease IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice

P2860

Q26752622-7E1161F4-0C98-49C0-B0E2-6E7A2EBF8DA4 Q26766654-7EE77438-D32E-4C41-864A-64B52FE53542 Q26773226-A9528EBC-73CB-416B-9019-A014C155245B Q26774699-D99800C9-3773-4EE6-AF4A-B8BC19333D8E Q27000742-C02AC993-DC3C-4640-A3F8-E201D2AC502C Q27027380-14600A50-DAB3-45A6-B321-07E66F88826E Q27687335-AB03837C-44F9-4BE5-A3E1-6D9CC8C1A34A Q28740922-B198E706-5FFD-4EA0-A8CA-0270CC974BD8 Q30252731-7943C3BC-9A22-4ED7-B332-F072CDCE835A Q30277911-DFB17DF3-F75D-4816-BE1A-38FC760C848D Q33364126-65BD2F57-BA09-44A7-87A0-DDB7AF883ED5 Q33671678-67FB0065-AEC2-40F6-88ED-68F4DE9D7310 Q33746508-8479D571-3589-4649-941C-434F5362D191 Q33746519-F0CA9866-3862-47E2-BEFD-20F5150A8A1D Q33818770-960A7E4A-5CDC-45C2-B2F0-B62DA389686D Q34054086-C7887BB8-3619-48AB-9121-8210C1C13DAC Q34089708-C41AE433-BF4D-463D-B371-5B2E4C10D033 Q34411311-BA01AF27-24C4-448D-92DD-269275381288 Q34467228-1AA53B33-01F7-4CD0-B998-FCFF343F5307 Q34571578-B22971EF-15AD-47E2-A994-922BA05BC58F Q34573878-82D2120C-C01C-4DCB-A78F-90590FC14432 Q34750539-521791BA-55F9-46B0-B812-19039E8CB8A1 Q34940989-37095E9A-6D4C-4243-8261-A090370DF6E0 Q35045751-C69AF710-2928-421D-BD6B-A01089C9C680 Q35167959-C3DA9396-E9F3-416F-B2ED-302B125FBC39 Q35276001-BC709779-8A20-4A38-8EC3-8C240E0A5776 Q35420938-12853779-9560-4CB4-BBB4-22989348AE78 Q35530956-C516832C-5A7F-41A6-93A6-78276531186D Q35673533-66C97FEA-8E4E-462D-BFB4-A251C2E9C7FA Q35710971-9DE80132-1DD0-4911-AECF-9E2ACB1EF070 Q35762773-54BBDA41-D728-476B-A502-E760DA50BA11 Q35867085-EBE76AB5-4A8D-483D-A2AB-0019C6A1CF39 Q35906051-96556B16-C9E5-41FB-8878-0280DDFEF2CA Q36001720-97FEF38C-C343-47EA-B9A1-B6A5B461F4BD Q36062404-94C3E354-BF78-4781-9D9A-7C8FEEB94082 Q36089631-0C3E9B7E-EB70-4CEA-9377-1B6C29D66E9E Q36108832-82A93000-F728-4B16-854F-0B0EB54ECC33 Q36188911-4F641BEF-BFC2-4EDA-A76B-1BF07D45926F Q36288405-E756BF1A-B70C-435A-8F27-F7103067CCF8 Q36474946-17A5BC80-3567-49C4-99CF-F81F969F501D

P2860

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

http://www.wikidata.org/entity/Q35074604

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

In vivo consequences of liver- ...... man liver disease progression.

@ast

In vivo consequences of liver- ...... man liver disease progression.

@en

type

label

In vivo consequences of liver- ...... man liver disease progression.

@ast

In vivo consequences of liver- ...... man liver disease progression.

@en

prefLabel

In vivo consequences of liver- ...... man liver disease progression.

@ast

In vivo consequences of liver- ...... man liver disease progression.

@en

P1433

Q35074604-7F5052DD-2B2E-46AA-A774-9606BEE82433

P1476

Q35074604-1847DA9F-5B5A-403F-AF43-CEFEEA024F6C

P2093

Q35074604-072302AC-0EDA-41A4-B0E1-042285648F20

Q35074604-22CC41E7-D793-4C83-806A-48D7A9BAAB58

Q35074604-35C591AA-2973-47C3-B04D-548823AD4471

Q35074604-5DA46640-1394-4869-B426-B65BD70F5129

Q35074604-714CBAF3-8EB8-4231-80FF-5F43CC5BE2EF

Q35074604-7D626BB3-3814-4F87-A968-8914B332AC1E

Q35074604-7EA9242E-E59D-4AA5-8916-47D5B02AD6C3

Q35074604-878E5596-3098-4961-93AD-54290B6D23AA

Q35074604-BD743089-3C55-4047-8717-F9E17C48FE66

Q35074604-C72D2E02-9217-4B14-9D4F-2EDB301EA99D

P2860

Q35074604-0532EA17-B113-48BA-8F9A-F61D2FFEB99D

Q35074604-0A9C834A-6C29-4918-82E6-8A5DA7D7396E

Q35074604-0B25505C-2750-4CE1-9648-6716E104B89D

Q35074604-16F512E4-4FCA-4AE5-BF6F-17089F6F9DCB

Q35074604-309374F7-2D14-4011-BB0C-A64E55C7BD6D

Q35074604-4727E60B-0D84-4750-90D6-04527FD8E740

Q35074604-4EB9E1D2-7420-4C4D-9916-A80973D2998D

Q35074604-52172A97-F7CF-4825-BDA0-F346B32FBA32

Q35074604-5258E7E9-74C0-4E3A-B8EC-8117E118F0FC

Q35074604-55CDE499-1579-49B6-993C-C4E7AF0DBC69

P304

Q35074604-D2AA150E-6A7C-448F-8584-77B8862EDC89

P31

Q35074604-D0059F9F-BDB9-4D92-851E-139B17310915

P356

Q35074604-5C0360DC-6F07-48B3-8712-0E2F5855339B

P407

Q35074604-2A3E4DEB-4B51-4876-9884-9EB1BAD4D93B

P433

Q35074604-078FF9A3-862E-4D2C-9E64-EDA7099F5C0D

P478

Q35074604-D6FC9407-BBD5-4A2C-B951-E8AD80D0DE39

P577

Q35074604-8F3B2EAC-0153-4750-91F4-07ED8847AE25

P5875

Q35074604-EED5EF97-21D7-4AFA-9319-C380FFD2F765

P698

Q35074604-627B4C9C-8835-4ADD-A11A-5D188BB04BB6

P932

Q35074604-284E7F0C-E800-41B2-B805-CDC8A3B8EC61

P356

P1433

P1476

In vivo consequences of liver- ...... man liver disease progression.

@en

P2093

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Fu-Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Hai Li

http://www.w3.org/2001/XMLSchema#string

Honglei Weng

http://www.w3.org/2001/XMLSchema#string

Howard A Young

http://www.w3.org/2001/XMLSchema#string

Hua Wang

http://www.w3.org/2001/XMLSchema#string

Lionel Feigenbaum

http://www.w3.org/2001/XMLSchema#string

Ogyi Park

http://www.w3.org/2001/XMLSchema#string

Seong Ho Yoo

http://www.w3.org/2001/XMLSchema#string

Shi Yin

http://www.w3.org/2001/XMLSchema#string

P2860

The biological functions of T helper 17 cell effector cytokines in inflammation

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

Biology of interleukin-22.

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

Activation of natural killer cells during acute infection with hepatitis C virus.

A novel role for IL-22R1 as a driver of inflammation.

Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

P304

252-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.24339

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51000634

http://www.w3.org/2001/XMLSchema#string

P698

21465510

http://www.w3.org/2001/XMLSchema#string

P932

3125432

http://www.w3.org/2001/XMLSchema#string